On July 15th, 2014, the Office of Technology Development at Boston University will host its fifth annual technology networking event entitled, Tech, Drugs, and Rock n’ Roll (TDRR), from 4-8pm in the Metcalf Ballroom of the George Sherman Union. TDRR is a networking event designed to connect scientists and engineers with entrepreneurs, investors, and innovators. The event […]
A recent study led by Boston University School of Medicine has demonstrated a novel approach to create an unlimited number of human red blood cells and platelets in vitro. In collaboration with Boston University School of Public Health and Boston Medical Center, the researchers differentiated induced pluripotent stem (iPS) cells into these cell types, typically […]
For over a decade, Drs. Edward Damiano (Associate Professor, Biomedical Engineering) and Firas El-Khatib (Senior Research Scientist) at Boston University have been developing a bihormonal bionic pancreas to help patients with type 1 diabetes (and insulin-dependent type 2 diabetes) control their blood glucose levels. The system integrates three components: a continuous glucose monitor, external infusion […]
April 11, 2013 at 3:06 pm
Dear Reader, Boston University has several “gap funding” programs managed by OTD. These allow BU research to advance towards commercialization leveraging government sponsored basic research funding. BU has a history of being an innovator in research commercialization. The Community Technology Fund established in 1975 was the first university venture fund. It invested in over 175 […]
April 11, 2013 at 3:03 pm
Our 2013 Life Science Awardees were Ulla Hansen, David Harris, Avrum Spira and Marc Lenburg, and Kenneth Walsh. All winners demonstrated potential for developing small and large molecule therapeutics in multiple therapeutic areas. Ulla Hansen, Professor of Biology, is developing small molecule LSF inhibitors for the treatment of liver cancer. The objective of this proposal […]
April 11, 2013 at 2:58 pm
Our 2013 High Tech Awardees were Assaf Kfoury, Douglas Densmore, Ramesh Jasti, and for developing commercial applications in Information Technology, Healthcare IT, and chemistry, respectively. Douglas Densmore, Assistant Professor in the Electrical and Computer Engineering Department , works on a high throughput, combinatorial, constraint-based DNA cloning software platform called Clotho. One approach in synthetic biology […]
April 11, 2013 at 2:53 pm
The Office of Technology Development is always working on creative ways to connect our research faculty with entrepreneurs and industry representatives. On February 28, Hiebert Lounge at BU Medical Campus played host to the second annual “Tech, Drugs, and Rock n’ Roll Unplugged” for over 100 attendees. The event was organized by BU’s Office of […]
November 20, 2012 at 3:27 pm
Dear Reader, Boston University has emerged as a significant research university in the past decade. We only began to offer PhDs in Engineering in 1991 and in 2001 our sponsored research revenues was about $200 million. This has almost doubled in the past decade. In the past two years our sponsored research funding from the […]
November 20, 2012 at 2:56 pm
Over the past decade, systems biologists have mapped large networks of protein interactions related to various diseased states, providing many potential new drug targets for the pharmaceutical industry. These targets are dissimilar to traditional drug targets, generally lacking natural small molecule ligands and being physically flatter than the cavities used by many drugs; presenting a […]
November 20, 2012 at 2:53 pm
In early October, Japanese scientist, Shinya Yamanaka shared the Nobel Prize for medicine or physiology with British researcher, John Gordon for discovering that bodily cells, such as skin or hair cells can be reprogrammed into stem cells: a brilliant discovery that has the potential of embryonic-like cells that can become any kind of tissue. When […]
